Xcout Intel
Bantam Pharmaceutical, LLC competitors & alternatives
The 12 closest competitors and alternatives to Bantam Pharmaceutical, LLC among biotechnology companies — ranked by similarity to what Bantam Pharmaceutical, LLC actually does, not by market-cap band.
Subscribe to see Bantam Pharmaceutical, LLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Bantam Pharmaceutical, LLC
Bantam Pharmaceutical, LLC is a clinical-stage biopharmaceutical company that develops novel, first-in-class small molecule oral therapeutics for oncology. The company targets mitochondrial dynamics to restore apoptosis in cancer cells, with a lead candidate focused on treating difficult hematological and solid tumors such as Diffuse Large B-cell Lymphoma.
Bantam Pharmaceutical, LLC at a glance
Bantam Pharmaceutical, LLC is a biotechnology company headquartered in United States. It has raised at least $32M across the 2 funding rounds on record. Its most recent funding round, Seed, raised $25M in September 2021. Xcout tracks 10 named people at Bantam Pharmaceutical, LLC, including MICHAEL STOCUM (PRESIDENT CEO).
Bantam Pharmaceutical, LLC leadership
- MICHAEL STOCUMPRESIDENT CEO
- Glen WeissCHIEF MEDICAL OFFICER
- Matthew KosturaCHIEF SCIENTIFIC OFFICER
- Michael LutherFounding CEO, Bantam Pharmaceutical CEO STRM.BIO Former Astellas, Merck GSK
- Meghan ReynoldsCHIEF OF STAFF
- Andy AnanthaHEAD OF CMC
4 more named people on record for Bantam Pharmaceutical, LLC, with roles, board committees and tenure — see the full roster →
Bantam Pharmaceutical, LLC funding rounds
At least $32M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $25M | — | |
| SEC Form D filing | $7M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Bantam Pharmaceutical, LLC competitors
Ranked by semantic similarity — how close each company is to Bantam Pharmaceutical, LLC by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Bio-Path Holdings, Inc. is a U.S.-based pharmaceutical company focused on developing RNAi nanoparticle drugs for oncology, with programs spanning both clinical and preclinical stages. Its innovative product development is centered around the DNAbilize platform, a drug delivery and antisense technology that employs a P-ethoxy modified deoxyribonucleic acid (DNA) backbone. This modification is specifically engineered to shield the DNA from premature degradation. The company's lead drug candidate, prexigebersen, is presently in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. Additionally, Bio-Path is advancing Liposomal Bcl-2 for refractory/relapsed lymphoma and chronic lymphocytic leukemia. Another promising asset, Liposomal STAT3, is in preclinical development, targeting pancreatic cancer, non-small cell lung cancer, and AML. Furthermore, prexigebersen-A is under development for various solid tumors. Bio-Path Holdings, Inc., founded in 2007, is headquartered in Bellaire, Texas.
Biotech
Pretzel Therapeutics is a biotechnology company headquartered in Boston, Massachusetts, advancing a new class of medicines that target cellular energetics and mitochondrial function.
Biotech
Oxford BioTherapeutics is a clinical-stage oncology company focused on developing first-in-class cancer therapeutics with a proprietary pipeline. The company operates from locations in Oxford, United Kingdom, as well as San Jose, California, and Morristown, New Jersey, in the United States.
Similar biotechnology company
ImmPACT Bio is a biotechnology company developing next-generation cancer immunotherapies, including dual-targeted CAR T-cell therapies. Its programs are intended to serve patients with B-cell malignancies and potentially other cancers, including solid tumors.
Biotech
Bellicum Pharmaceuticals, Inc. is a company focused on engineering high-performance cellular immunotherapies. These therapies are developed to combat diseases.
Biotech
Whitehawk Therapeutics Inc. is a biopharmaceutical enterprise currently undergoing clinical trials. This company specializes in crafting highly targeted treatment options for cancers that are identified by distinct genetic profiles.
Similar biotechnology company
Vibrant Therapeutics is a clinical-stage biotechnology company headquartered in Cambridge, Massachusetts, with operations in China. Founded in July 2019, the firm focuses on revolutionizing protein drug discovery and developing next-generation prodrugs with precise targeting.
Similar biotechnology company
Kurome Therapeutics is a biotechnology company developing targeted therapies for hematopoietic cancers and cancer cells that co-opt immune signaling or over-activated pathways to resist traditional treatment. Launched in 2020 with support from CincyTech, the company has synthesized thousands of derivatives from initial compounds to address adaptive resistance mechanisms.
Similar biotechnology company
D3 Bio is a biopharmaceutical company headquartered in Shanghai, China, focused on the discovery and development of innovative oncology and immunology medicines.
Similar biotechnology company
Breakthru Medicine is a privately held biotechnology company headquartered in Phoenix, Arizona. Founded in 2024 by oncology experts, the company advances a portfolio of innovative cancer therapeutics designed to address critical unmet clinical needs.
Similar biotechnology company
Ayala Pharmaceuticals, Inc. is a biopharmaceutical company headquartered in Monmouth Junction, New Jersey. The company focuses on developing targeted therapeutics for rare tumors and aggressive cancers. It engages in clinical research and asset management within the biotechnology and pharmaceutical sector.
Biotech
Blossomhill Therapeutics, Inc. is a biopharmaceutical company. It engages in the development of small molecule medicines for unmet medical needs in cancer treatment. The company was founded in June 2020 and is headquartered in San Diego, CA.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Bantam Pharmaceutical, LLC and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Bantam Pharmaceutical, LLCand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →